# Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

Study · id `cardio:ct-nct04893291` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04893291](<https://clinicaltrials.gov/study/NCT04893291>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04893291

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1820 participants.

## Technical summary

Registry record NCT04893291. Randomized; no masking; primary purpose treatment. Start 2021-11-16 (actual); primary completion 2026-08-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1820 participants (planned count; ClinicalTrials.gov record NCT04893291, source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)
- Started: 2021-11-16 (actual) (ClinicalTrials.gov record NCT04893291, source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)
- Primary completion: 2026-08-30 (anticipated) (ClinicalTrials.gov record NCT04893291, source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)
- Completion: 2030-08-30 (anticipated) (ClinicalTrials.gov record NCT04893291, source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)
- Countries: Bangladesh; Brazil; Brunei; France; Italy; Malaysia; Netherlands; Poland; Spain; Thailand; United Kingdom (ClinicalTrials.gov record NCT04893291, source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04893291-2026-02-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
- Acronym: TRANSFORM II
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Stenosis
- Intervention (Device): Everolimus Eluting Stent
- Intervention (Device): Sirolimus Coated Balloon
- Lead sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS (`cardio:org-fondazione-ricerca-e-innovazione-cardiovascolare-ets`)

## Provenance

Content hash: ca0fc2fb96f782418656152f2cedf2e198e0a8088a1f9828b4db010471021c56
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
